| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Actinium Pharmaceuticals (AMEX:ATNM) through any online brokerage.
Other companies in Actinium Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Actinium Pharmaceuticals has a consensus price target of $10.20.
The stock price for Actinium Pharmaceuticals (AMEX: ATNM) is $1.47 last updated October 20, 2026 at 12:40 PM EDT.
There are no upcoming dividends for Actinium Pharmaceuticals.
Actinium Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Actinium Pharmaceuticals.
Actinium Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
